drugset / Trial / NCT05723315
Effect of rhBNP on CMD in Patients With STEMI After PPCI
RandomizedParallel-groupTriple-blindTreatment
Summary
The target population of this interventional study was STEMI patients. Primary discussion: Early rhBNP reduces microcirculation obstruction in STEMI patients undergoing primary PCI
Timeline
- Start
- 2023-02-20
- Primary completion
- 2024-12-20
- Completion
- 2025-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | recombinant human B-type natriuretic peptide | Peptide | 0.015 ug/kg | Intravenous |